{"prompt": "['Novartis', 'Confidential', 'Page 6', 'Clinical Trial Protocol (Version 00)', 'Protocol No. CQAW039A2316', 'List of Abbreviations', 'Abbreviation', 'Explanation:', 'ACR', 'albumin-creatinine ratio', 'ACQ', 'asthma control questionnaire', 'AE(s)', 'adverse event(s)', 'Alb', 'albumin', 'ALT', 'alanine aminotransferase', 'ANCOVA', 'analysis of covariance', 'AQLQ+12', 'asthma quality of life questionnaire for 12 years and older', 'ALP', 'alkaline phosphatase', 'AST', 'aspartate aminotransferase', 'ATC', 'anatomical therapeutic chemical', 'ATS/ERS', 'American Thoracic Society/European Respiratory Society', 'AV', 'atrioventricular', 'BMI', 'body mass index', 'BTPS', 'body temperature and pressure saturated', 'BUN', 'blood urea nitrogen', 'CFR', 'Code of Federal Regulations', 'CK', 'creatine kinase', 'CK-MB', 'creatine kinase isoenzyme MB', 'CPO', 'Country Pharma Organization', 'COA', 'clinical outcome assessment', 'CRA', 'clinical research associate', 'CRF', 'case report/record form (paper or electronic)', 'CRO', 'contract research organization', 'CRTh2', 'chemoattractant receptor-homologous molecule expressed on Th2', 'CT', 'computed tomography', 'DAR', 'dosage administration record', 'DDE', 'direct data entry', 'DNA', 'deoxyribonucleic acid', 'DP2', 'prostaglandin D2 receptor 2', 'DPI', 'dry powder inhaler', 'DMC', 'Data Monitoring Committee', 'DRESS', 'drug reaction with eosinophilia and systemic symptoms', 'DS&E', 'Drug Safety & Epidemiology', 'ECG', 'electrocardiogram', 'EDC', 'electronic data capture', 'eGFR', 'estimated glomerular filtration rate', 'EMA', 'European Medicines Agency', 'ePEF', 'electronic peak expiratory flow', 'EU', 'European Union', 'FAS', 'full analysis set', 'FDA', 'Food and Drug Administration']['Novartis', 'Confidential', 'Page 7', 'Clinical Trial Protocol (Version 00)', 'Protocol No. CQAW039A2316', 'Abbreviation', 'Explanation:', 'FDC', 'fixed dose combination', 'FEV1', 'forced expiratory volume in 1 second', 'Y-GT', 'gamma-glutamyltransferase', 'GCP', 'good clinical practice', 'GINA', 'Global Initiative for Asthma', 'GOLD', 'Global Initiative For Chronic Obstructive Lung Disease', 'Ho', 'null hypothesis', 'Ha', 'alternative hypothesis', 'HbA1c', 'hemoglobin A1c; glycosylated hemoglobin', 'hCG', 'human chorionic gonadotropin', 'HFA', 'hydrofluoroalkane', 'HRQOL', 'health-related quality of life', 'hsCRP', 'high sensitivity C-reactive protein', 'IB', 'investigator brochure', 'ICH', 'international conference on harmonization of technical requirements for', 'registration of pharmaceuticals for human use', 'ICS', 'inhaled corticosteroid', 'IDR', 'idiosyncratic drug reactions', 'IEC', 'independent ethics committee', 'IgE', 'immunoglobulin E', 'ImmunoCAPR', 'specific IgE test', 'IN', 'investigator notification', 'INR', 'international normalized ratio', 'IRB', 'institutional review board', 'IRT', 'interactive response technology', 'ITT', 'intention-to-treat', 'IUD', 'intrauterine device', 'IUS', 'intrauterine system', 'LABA', 'long-acting \u00df-agonist', 'LAMA', 'long-acting muscarinic antagonist', 'LDH', 'lactate dehydrogenase', 'LFT', 'liver function test', 'LTRA', 'leukotriene receptor antagonist', 'MAR', 'missing at random', 'MedDRA', 'medical dictionary for regulatory activities', 'MDI', 'metered dose inhaler', 'MDRD', 'modification of diet in renal disease study', 'MID', 'minimal important difference', 'MMRM', 'mixed model repeated measures', 'MXR', 'multi-xenobiotic resistance protein', 'NYHA', 'New York Heart Association']\n\n###\n\n", "completion": "END"}